Carasent AB (publ) (STO:CARA)
Sweden · Delayed Price · Currency is SEK 23.40
-0.70 (-2.90%)
Mar 2, 2026, 5:09 PM CET
Carasent AB Market Cap
Carasent AB has a market cap or net worth of 1.65 billion as of March 2, 2026. Its market cap has decreased by -5.33% in one year.
Market Cap
1.65B
Enterprise Value
1.54B
Revenue
343.82M
Ranking
n/a
PE Ratio
52.72
Stock Price
23.40
Market Cap Chart
Since December 12, 2012, Carasent AB's market cap has increased from 48.86M to 1.65B, an increase of 3,277.32%. That is a compound annual growth rate of 30.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 1.65B | -14.05% |
| Dec 30, 2025 | 1.92B | 19.57% |
| Dec 30, 2024 | 1.61B | 3,186.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 136.67B |
| Getinge AB | 55.26B |
| Sectra AB | 37.34B |
| Medicover AB | 32.84B |
| Cereno Scientific AB | 1.98B |
| Egetis Therapeutics AB | 1.81B |
| Stille AB | 1.71B |
| EQL Pharma AB | 1.68B |